These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24187716)

  • 1. [Not Available].
    Adamkova V
    Vnitr Lek; 2013 Sep; 59(9):759. PubMed ID: 24187716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of natriuretic peptides in diagnosis of left ventricular hypertrophy in obese hypertensive patients with metabolic syndrome].
    Spác J; Beránek M; Němcová H; Kianička B; Souček M
    Vnitr Lek; 2013 Sep; 59(9):769-75. PubMed ID: 24073948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-BNP/BNP for screening left ventricular hypertrophy in hypertension: what else?
    Isnard R
    Arch Cardiovasc Dis; 2008 May; 101(5):295-7. PubMed ID: 18656086
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma brain natriuretic peptide in athletes.
    Yamazaki H; Senju Y; Kinoshita N; Katsukawa F; Onishi S
    Am J Cardiol; 2000 Jun; 85(11):1393-4. PubMed ID: 10831966
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic value of NT-ProBNP for left ventricular hypertrophy in hemodialysis patients.
    Maoujoud O; Asseraji M; Aatif T; Zajjari Y; Bahadi A; Benyahya M; Tellal S
    Int J Artif Organs; 2013 Jun; 36(6):419-20. PubMed ID: 23653297
    [No Abstract]   [Full Text] [Related]  

  • 6. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical use of NT-PRO-BNP in end stage renal failure patients].
    Heras M; Fernández Reyes MJ; Guevara P; Sánchez R; González M; Velasco S; García Arévalo MC; Alvarez-Ude F
    Nefrologia; 2005; 25(6):698-702. PubMed ID: 16514911
    [No Abstract]   [Full Text] [Related]  

  • 8. [Usefulness of BNP measurement for stratifying cardiovascular risk in hypertensive patients].
    Waeber B; Feihl F
    Rev Med Suisse; 2011 Sep; 7(308):1748-50. PubMed ID: 21954815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study.
    Morillas P; Castillo J; Quiles J; Nuñez D; Guillén S; Maceira A; Rivera M; Bertomeu V
    Rev Esp Cardiol; 2008 Sep; 61(9):972-5. PubMed ID: 18775240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide--a promising biomarker for the diagnosis of left ventricular hypertrophy in hypertensive women.
    Mouly-Bertin C; Bissery A; Milon H; Dzudie A; Rabilloud M; Bricca G; Vincent M; Lantelme P
    Arch Cardiovasc Dis; 2008 May; 101(5):307-15. PubMed ID: 18656089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [N-terminal pro-brain natriuretic peptide and cardiac involvement in patients with hypertensive disease].
    Kostoeva AU; Mazur NA; Masenko VP; Sbrodova LV; Babaev FZ; Volkov VE; Pshenitsin AI; Khezheva FM; Shestakova NV
    Kardiologiia; 2009; 49(12):33-8. PubMed ID: 20038279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma lactate level is associated with subclinical cardiovascular damage in patient with non-dipping hypertension.
    Lian H; Zhuo SQ; Tian XT; Liu FC
    Clin Exp Hypertens; 2016; 38(6):541-4. PubMed ID: 27399330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension, echocardiographically determined left ventricular hypertrophy and N-terminal pro-B type natriuretic peptide levels in women population aged 56-65 years].
    Shipilova T; Pshenichnikov I; Anier A; Borodin A; Riipulk E; Karaĭ D; Meĭgas K; Kaĭk Iu
    Kardiologiia; 2009; 49(7-8):56-61. PubMed ID: 19656109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of N-terminal pro-B-type natriuretic peptide levels to electrocardiography criteria for detection of left ventricular hypertrophy: the ARIRANG study.
    Ahn MS; Yoo BS; Lee JH; Lee JW; Youn YJ; Ahn SG; Kim JY; Lee SH; Yoon J; Park JK; Ahn SV; Choi E
    J Korean Med Sci; 2015 Apr; 30(4):407-13. PubMed ID: 25829808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension.
    Partanen N; Husso M; Vuolteenaho O; Sipola P; Ruskoaho H; Peuhkurinen K; Magga J
    J Hum Hypertens; 2011 Dec; 25(12):746-51. PubMed ID: 21248782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides in patients with aortic stenosis.
    Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
    Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.